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Abstract
We previously reported that aged mice lacking complement factor H (CFH) exhibit visual defects and structural changes in
the retina. However, it is not known whether this phenotype is age-related or is the consequence of disturbed development.
To address this question we investigated the effect of Cfh gene deletion on the retinal phenotype of young and mid-age
mice. Cfh2/2 mouse eyes exhibited thickening of the retina and reduced nuclear density, but relatively normal scotopic and
photopic electroretinograms. At 12 months there was evidence of subtle astroglial activation in the Cfh2/2 eyes, and
significant elevation of the complement regulator, decay-accelerating factor (DAF) in Mu¨ller cells. In the retinal pigment
epithelium (RPE) of young control and Cfh2/2 animals mitochondria and melanosomes were oriented basally and apically
respectively, whereas the apical positioning of melanosomes was significantly perturbed in the mid-age Cfh2/2 RPE. We
conclude that deletion of Cfh in the mouse leads to defects in the retina that precede any marked loss of visual function, but
which become progressively more marked as the animals age. These observations are consistent with a lifelong role for CFH
in retinal homeostasis.
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Introduction
Age-related macular degeneration (AMD) is the most common
cause of blindness in the western world, yet the underlying
molecular pathology is poorly understood [1]. A number of single-
nucleotide polymorphisms (SNPs) in genes encoding proteins of
the complement system have been linked to increased risk of
developing AMD. The first to be described, and the best
characterised, is a SNP in complement factor H (CFH) that
changes a tyrosine to a histidine at position 402 [2–6]. CFH
functions as a negative regulator of complement activation, in part
by binding to serum proteins such as complement C3, heparin and
C-reactive protein [7]. CFH also binds to various products of lipid
peroxidation to suppress inflammation and macrophage infiltra-
tion into the eye. However, recent investigations have shown that
the AMD-associated CFH402H variant exhibits decreased binding
to malondialdehyde and oxidized phospholipids and is associated
with increased complement activation [8,9].
In previous work we used mice containing a targeted disruption
of the Cfh gene to investigate the role of CFH in the retina [10].
The Cfh2/2 mice were originally developed as a model of
membranoproliferative glomerulonephritis, which manifests in
these animals as a consequence of uncontrolled C3 activation [11].
In two-year old Cfh2/2 mice, we observed a number of
abnormalities including reduced visual acuity and loss of rod
function, and structural changes to the photoreceptors and Bruch’s
membrane but it is not known when these functional and
anatomical abnormalities begin in Cfh2/2 mice. In a separate
study we performed a microarray analysis of neural retina and
retinal pigment epithelium (RPE) from these mice to investigate
the consequences of Cfh deletion on age-related changes in gene
expression, and observed anomalies in the expression patterns of
certain complement regulators as a function of age [12].
These studies suggest that CFH has a homeostatic or protective
role in the retina, a notion further supported by work showing that
suppression of CFH expression in the mouse eye using siRNA
leads to a more aggressive response to laser-induced choroidal
neovascularisation [13]. Although there are recognised differences
between the human and mouse complement systems [14], studies
in mice may nevertheless provide insight into the role of CFH in
the human retina. Here we analysed the phenotype of the 12
month old Cfh2/2 mouse retina to determine whether the
abnormalities in two year-old mice represent the culmination of
a lifelong deterioration or are an early consequence of disturbed
development.
Results
We first assessed whether the loss of CFH caused any
morphological disorganisation in the retinas of young or 1 year
Cfh2/2 mice. We compared Cfh2/2 mice at 7–8 weeks (young)
and 1 year (mid-age), and used wild-type age-matched controls to
monitor changes associated with normal ageing. Semi-thin resin
sections were cut from fixed eyes in all four groups and stained
with toluidine blue (Figure 1, A-D). We observed a greater
tendency for photoreceptor detachment in the 1 year Cfh2/2
samples than in aged-matched wild-type samples and a modest
increase in retinal thickness. Quantification of retinal thickness, as
measured from the inner limiting membrane (ILM) to the RPE at
a position 0.5 mm from the optic nerve head, confirmed a small
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but significant thickening of the retina in the Cfh2/2 mice that was
already present at 7–8 weeks and that remained relatively stable
up to one year (Figure 1E). Quantification of the nuclei in the
outer nuclear layer (ONL) revealed that there was a small
reduction in photoreceptor density with age in both wild-type and
Cfh2/2 mice however this trend did not reach statistical
significance (Figure 1F). Whilst wild-type and Cfh2/2 nuclear
densities were not significantly different at 7–8 weeks, they became
so by mid-age, with accelerated photoreceptor cell loss in the
Cfh2/2 retinas.
In order to assess whether the morphological changes described
here had any functional significance we performed ERGs. Dark-
adapted 1 year Cfh2/2 and age-matched wild-type mice were
exposed to flashes of light of increasing intensity. Overlaid scotopic
ERG traces from both Cfh2/2 and wild-type mice showed clear a-
and b- waves (Figure 2, A and B). Retinal function was assessed
between groups by comparing the amplitude and time to peak for
each wave. The amplitudes of both the a- and b-waves were not
significantly different in 1 year Cfh2/2mice compared to wild-type
controls, and were similar to values reported in other 1 year
pigmented mice (Figure 2, C and D) [15]. However, the time to
reach the peak of the a-wave wave was increased significantly in
the 1 year Cfh2/2 mice compared to wild-type (p= 0.004;
Figure 2E) whereas the increased trend in the b-wave did not
reach significance (Figure 2F). An unpaired Student t-test for each
light intensity revealed that half of the a-wave measurements were
significantly increased in Cfh2/2 mice.
After recording scotopic ERGs, mice were light-adapted for
photopic ERGs in order to assess their cone-mediated responses.
Overlaid photopic ERG traces from both Cfh2/2 and wild-type
mice showed small a-wave responses at low light intensities but
clear b-wave responses at higher light intensities (Figure 3, A and
B). Measurements of the a- and b-wave amplitudes showed no
significant difference between 1 year Cfh2/2 and age-matched
wild-type controls (Figure 3, C and D). There were also no
significant differences in the time to peak for both the a- and b-
wave responses (Figure 3, E and F). These results suggest that
cone-mediated vision is unaffected by the loss of CFH in mice at 1
year of age. VEPs were recorded simultaneously to confirm that
neuronal stimulation in the eye elicited subsequent neuronal
activity in the visual cortex. VEP recordings from both Cfh2/2 and
wild-mice showed a negative wave that followed the b-wave of the
ERG, indicating normal neural transmission (data not shown).
Comparing the amplitude and time to peak for the negative wave
Figure 1. Loss of CFH causes thickening of the retina and reduced nuclear density in the outer nuclear layer. Toluidine blue stained
2 mm semithin sections of (A and B) wild-type and (C and D) Cfh2/2 mouse eyes at age 7–8 weeks (A and C) and one year (B and D). Retinal thickness
(E) was calculated from the ILM to RPE. Data are means6 S.D., n = 3. Average nuclei number (F) was calculated per 100 mm2 area of the ONL. Data are
means 6 S.D., n = 5. Student t-tests were applied to data, *p =,0.05. Scale bar represents 20 mm.
doi:10.1371/journal.pone.0068616.g001
Retinal Phenotype of the CFH Knockout Mouse
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of Cfh2/2 to wild-type mice did not show any significant
differences.
In order to perform detailed ultrastructural examination of the
RPE, transmission electron micrographs were prepared from 7–8
week and 1 year Cfh2/2 and wild-type mice (Figure 4, A-D). In 2
year wild-type mice, electron-dense material accumulates in the
basal region within the RPE but this is decreased in Cfh2/2 retinas
[10]. In both young and 1 year old samples, electron micrographs
showed clear basal infoldings with no sign of any accumulation of
electron-dense material towards the basal surface. In both Cfh2/2
and wild-type samples there was an expected increase in lipofuscin
with age which is consistent with previous studies [16], although
levels of lipofuscin did not appear significantly different between
genotypes.
In the 2 year Cfh2/2 animals melanin and lipofuscin-containing
organelles were more evenly distributed throughout the cell
compared to age-matched wild-type controls where they were
predominantly apical [10]. Here, we analysed the distribution of
both mitochondria and melanosomes in the RPE of young and
mid-age Cfh2/2 and age-matched wild-type mice (Figure 4, E and
F). The cross-sectional depth of the RPE cells, measured from the
basal lamina to the base of the apical processes, was not
significantly different across the four groups with an average
height of 5 mm. Mitochondria are normally localised towards the
basal side of RPE where there is a large energy demand [17], and
the distribution of mitochondria was not significantly affected by
the loss of CFH at 7–8 weeks (Figure 4E). However, ageing caused
mitochondria in wild-type RPE to become slightly less polarised
and they were on average further from the basal lamina which is
Figure 2. Electroretinogram response to light under scotopic conditions in wild-type and Cfh2/2 mice. Electrophysiological assessment
of retinal function by electroretinogram (ERG) was performed on one year old Cfh2/2 and wild-type mice. Dark-adapted mice were used to assess
scotopic neural retinal responses. Representative ERG traces (A and B) in response to flash stimuli of increasing log intensity. Mean amplitude of a-
wave (C) and b-wave (D) measured from wild-type (blue line) and Cfh2/2 (red line) mice. Time to peak of the a-wave (E) and b-wave (F) measured
from wild-type and Cfh2/2mice. WT n= 6, KO n=5. Unpaired Student’s t-tests were applied to data, *p,0.05, **p,0.01. ANOVA showed a significant
increase in time to peak of a-wave (p,0.01).
doi:10.1371/journal.pone.0068616.g002
Retinal Phenotype of the CFH Knockout Mouse
PLOS ONE | www.plosone.org 3 July 2013 | Volume 8 | Issue 7 | e68616
consistent with published data [18]. In 1 year Cfh2/2 samples we
observed the opposite whereby mitochondria remained signifi-
cantly closer to the basal lamina.
Melanosomes are typically polarised towards the apical surface
of RPE. Their position is suited to the absorption of scattered light,
and thus protection of the basally arranged mitochondria from
free radical generation. In wild-type retinas, melanosomes were on
average 2 mm further from the basal lamina than mitochondria
and their position was not altered with ageing (Figure 4F).
However, in the RPE of young Cfh2/2 mice, melanosomes were
slightly more apical than in wild-type mice. In contrast, in 1 year
Cfh2/2 retinas, the opposite was observed, in that melanosomes
were significantly less polarised. These analyses show that in 1 year
Cfh2/2 samples the basal polarity of mitochondria was accentu-
ated, whereas there was a significant loss of apical polarity of
melanosomes.
Next we examined the expression of glial fibrillary acidic protein
(GFAP), a marker of retinal stress. In the wild-type and young
Cfh2/2 retinas GFAP expression was restricted to astroglia in the
ganglion cell layer (GCL) (Figure 5, A and B). However, in 1 year
Cfh2/2 mice the GFAP positive cell processes were more
disorganised than the structures seen in the control retinas and
were seen extending towards the inner plexiform layer (IPL)
(Figure 5, C and D), providing evidence of astroglial activation in 1
year Cfh2/2 retinas. Finally, we investigated the expression of
decay-accelerating factor (DAF) which, like CFH, can potentiate
the decay of C3 convertases. Staining of DAF in retinal sections
revealed positive staining in the GCL in wild-type mice which was
unaffected by age (Figure 6, A and B). This expression pattern
matched that observed in young Cfh2/2 mice (Figure 6C), whereas
in the 1 year Cfh2/2 retina, DAF-positive projections extended
from the GCL into the IPL (Figure 6D). Positive staining was also
Figure 3. Electroretinogram response to light under photopic conditions in wild-type and Cfh2/2mice. Electrophysiological assessment
of retinal function by electroretinogram (ERG) was performed on one year old Cfh2/2 and wild-type mice. Light-adapted mice were used to assess
photopic neural retinal responses. Representative ERG traces (A and B) in response to flash stimuli of increasing log intensity. Mean amplitude of a-
wave (C) and b-wave (D) measured from wild-type (blue line) and Cfh2/2 (red line) mice. Time to peak of the a-wave (E) and b-wave (F) measured
from wild-type and Cfh2/2 mice. WT n= 6, KO n= 5.
doi:10.1371/journal.pone.0068616.g003
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Figure 4. Organelle positioning in the retinal pigment epithelium. Transmission electron micrographs of 70–80 nm sections of RPE from (A &
B) 7–8 week old and (C & D) 1 year old (A & C) wild-type and (B & D) Cfh2/2 mice. Scale bars represent 1 mm. In (A) an illustrative scale bar (yellow)
shows how the positions of melanosomes (m) and mitochondria (mt) were mapped, so that the distances of (E) mitochondria and (F) melanosomes
were measured from the basal lamina. Each scatter plot shows quantification of .500 mitochondria or .750 melanosomes per group where each
dot represents one organelle. *P,0.05; ***P,0.001. n = 5.
doi:10.1371/journal.pone.0068616.g004
Retinal Phenotype of the CFH Knockout Mouse
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present amongst the nuclei of the inner nuclear layer (INL) and in
the outer plexiform layer (OPL) but did not extend into the ONL.
Based on the pattern of DAF staining, it is unlikely that the DAF
positive processes are the same as those positive for GFAP. We
therefore performed double labelling of retinal sections from 1
year Cfh2/2 mice for DAF (Figure 7A) and the Mu¨ller cell marker,
glutamine synthetase (Figure 7B). Glutamine synthetase was
expressed in Mu¨ller cells extending from the GCL to the outer
limiting membrane (OLM) however because the primary antibody
was raised in mouse, the secondary anti-mouse IgG also stained
retinal blood vessels (Figure 7B). A merged image showed that
DAF positive cells were also positive for glutamine synthetase
(Figure 7C) indicating that DAF is up-regulated in Mu¨ller cells.
However, DAF positive regions of Mu¨ller cells were evident from
the GCL to the OPL but did not extend as far as the OLM. High
power images of the areas in white boxes show the areas of co-
localisation more clearly (Figure 7 D-F).
Discussion
CFH is one of many complement regulatory genes expressed in
the retina [19]. The main site of CFH synthesis within the retina
appears to be the RPE [20], from where it may be secreted directly
into retina to provide localised protection against unwanted
complement activation. Experiments using primary RPE cells in
culture revealed enhanced CFH secretion in response to inflam-
matory stimuli, suggesting that inflammation in AMD may lead to
disturbances in retinal complement homeostasis [21]. Various
mouse models have been developed that recapitulate some of the
features of AMD, such as subretinal deposits, lipofuscin accumu-
lation and choroidal neovascularisation, but thus far none have
been established based on the high-risk haplotypes that predispose
humans to AMD. One study reported transgenic mice in which
mouse-human chimaeric CFH variants were expressed as
transgenes against the Cfh2/2 background. However, whilst
certain AMD-like features developed with time in these animals,
there was no difference between the CFH402H and CFH402Y
variants [22]. Although the Cfh2/2 mouse is not a model for
AMD, it does give an insight into the role of complement
regulation in the retina that in turn may advance our
understanding of how complement dysfunction contributes to
the development of AMD.
CFH and other complement genes exhibit changes in their
expression levels as the retina ages [12,23]. Ageing leads to
structural and functional changes in all compartments of the retina
including the neuroretina, RPE, Bruch’s membrane and ocular
perfusion. In this study we observed several features that were
consistent with normal ageing in wild-type mice such as
accumulation of lipofuscin in the RPE, a decrease in photorecep-
tor density, a higher propensity for the photoreceptors to detach
and loss of polarisation of RPE mitochondria. The majority of
these changes also occurred in Cfh2/2 mice, with the exception of
the loss of polarisation of mitochondria. Indeed, we observed that
mitochondria became more polarised with ageing in Cfh2/2 mice.
The reasons for this are not obvious, but it could be a response to
changes in localised energy demands within the RPE or a decrease
in height of the basal infoldings.
The young wild-type and Cfh2/2 retinas were similar with
regard to DAF and GFAP staining, photoreceptor density and
visual function. However, as the mice aged we began to observe
changes in the Cfh2/2 retinas consistent with those previously
observed at two years. As in two year old Cfh2/2 mice, the
photoreceptors at one year showed a greater tendency to detach
from the apical processes of the RPE compared to age-matched
wild-type controls. Furthermore, thinning of the photoreceptors
was enhanced in one year Cfh2/2 mice whilst retinal thickness was
increased. The former may be due to a combination of
neuroretinal stress and RPE dysfunction leading to photoreceptor
drop-out whilst the latter may be due to increased blood-retinal
barrier permeability or decreased bulk flow of water resulting in
mild oedema. In the one year Cfh2/2 mice there was no significant
difference in the amplitudes of either the a- or b-wave under
scotopic conditions from age-matched wild-type controls. This
shows that the ERG changes observed in the two year old Cfh2/2
mice were a consequence of combined CFH knockout and age.
However, we did see an increased time to peak of the scotopic a-
wave in one year Cfh2/2 mice compared to age-matched wild-type
controls. This is perhaps an early indicator of the more extensive
loss of visual function seen in older animals.
Immunohistochemical analysis did not reveal any stress-related
redistribution of opsins in the photoreceptors (not shown), however
we did find early signs of mild retinal stress in astroglia of one year
Cfh2/2 mice, characterised by GFAP staining. Since glial cells
have an intimate relationship with the retinal vasculature, one
cause of the glial activation could have been as a reaction to
pathological changes to the retinal vasculature. Indeed a study on
one year old Cfh2/2 mice proposed a role for CFH in ocular
perfusion [24]. These investigators reported that the deep plexus
of the retinal vessels is withered due to deposition of C3b along
endothelial surfaces. However, in this study we observed that the
retinal vasculature appeared normal in both young and one year
Cfh2/2 mice and that there was no sign of C3b deposition on
endothelial surfaces (data not shown). It is possible that systemic
changes in the mouse due to C3 consumption in the serum lead to
retinal stress without causing structural changes in the vasculature.
Nevertheless, the presence of both structural and functional
changes, although subtle in the one year Cfh2/2 mice, indicates
that the absence of CFH leads to a mild chronic and progressive
retinal pathology.
We recently reported that Cfh gene deletion leads to changes in
expression of other complement regulators [12], and here we
observed significant up-regulation of DAF in Mu¨ller cells.
Consistent with previous studies in human AMD eyes [19] we
observed DAF expression in the GCL in young Cfh2/2 and
control mouse eyes. DAF has also been identified in human
vitreous, where it was proposed to function with membrane
cofactor protein and CD59 to control complement activation [25].
Here, the up-regulation of DAF in Mu¨ller cells within the inner
layers of the retina is consistent with a compensatory response to
the loss of CFH, reinforcing the importance of regulating
complement activation in the retina.
In summary, we have shown that at a young age there are no
significant changes in the retina of the Cfh2/2 mouse other than a
modest overall thickening. Additionally we show that whilst a
number of anatomical and ultrastructural changes are evident by
one year in the Cfh2/2 mice, many of the more marked structural
and functional changes identified in 2 year Cfh2/2 mice are not
yet present at this time. This highlights the importance of ageing as
a predisposing factor in the pathology of Cfh2/2 deficiency.
Materials and Methods
Animals
Cfh2/2 mice were a generously provided by Prof. Matthew
Pickering (Imperial College) and have been described previously
[10,11]. Ex-breeding C57Bl/6J control mice of 6–9 months were
purchased from Harlan Laboratories, and young C57Bl/6J mice
were bred in house in the Biological Resources Unit at the
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Institute of Ophthalmology. The experiments described in this
study were carried out under licence from the UK Home Office
and following approval from the UCL Institute of Ophthalmology
Ethical Review Panel. Mice were killed with a rising CO2
concentration with subsequent cervical dislocation, and eyes were
removed immediately. Mice were used at either 7–8 weeks or 1
year 611 days.
Figure 5. GFAP expression in astrocytic glial cells in Cfh2/2 and wild-type mice. 12 mm sections from young (A and B) and one year (C and
D) wild-type and Cfh2/2 fixed mouse eyed were stained for GFAP (red) and nuclei (blue). Sections were imaged using confocal and differential
interference contrast microscopy. Arrows indicate astrocytic processes extending into IPL. GCL, ganglion cell layer; IPL, inner plexiform layer; INL,
inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer; PR, photoreceptors. Images are representative of three independent
experiments. Scale bar = 20 mm.
doi:10.1371/journal.pone.0068616.g005
Figure 6. Decay-accelerating factor expression in aged Cfh2/2mice. 12 mm PFA-fixed sections from young (A and B) and old (C and D) wild-
type (A and C) and Cfh2/2 (B and D) retinas were stained for DAF (green) and nuclei (blue). Sections were imaged using confocal microscopy. GCL,
ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer; PR, photoreceptors. Images
are representative of three independent experiments. Scale bar = 20 mm.
doi:10.1371/journal.pone.0068616.g006
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Electroretinograms and Visual Evoked Potentials
Electroretinogram (ERG) and visual evoked potential (VEP)
recordings were performed as described previously [26]. Briefly,
mice were dark-adapted overnight and prepared for recordings
under dim red illumination. Mice were anaesthetised by intraper-
itoneal injection with ketamix, 2 ml/g body weight (37.5%
ketamine, 25% Dormitor, Fort Dodge Animal Health Ltd) and
10 ml atropine sulphate (600 mg/ml, Hameln Pharmaceuticals).
Stimuli for the scotopic recordings were brief full field flashes of
white light from darkness at varying intensity (-5.5 to 1 log cd/s/
m2) by altering both the duration (3 ms-1 ms) and attenuation
(1000-1) of the stimulus. The frequency of the flashes was 0.67 Hz
at lower intensities, which was decreased to 0.33 and 0.17 Hz at
the intermediate and higher intensities. For photopic recordings,
mice were light adapted in the recording chamber for 20 min with
a rod adapting background light (20 cd). Background light was
maintained throughout photopic recordings where brief full field
flashes of white light were applied at varying intensity (-1.4 to 1 log
cd/s/m2) by altering both the duration (1–3 ms) and attenuation
(1000-1) of the stimulus. The frequency of flashes was 0.5 Hz.
Electron Microscopy
For ultrastructural analysis all samples were prepared in the
afternoon. For analysis of the RPE, enucleated eyes were
immersed in Karnovsky’s fixative (3% glutaraldehyde (EM
grade-TAAB, G002), 1% paraformaldehyde in 0.07 M sodium
cacodylate (Agar Scientific, R1104), pH 7.4) for 2 h at RT.
Sectioning and imaging were performed as described previously
[26].
Organelle Distribution Analysis
RPE cell organelle distribution was analysed from captured
transmission electron micrographs of RPE cells in which the
nucleus was not visible. Mitochondria were identified by their
characteristic internal membraneous stacks, and melanosomes by
their uniform electron dense appearance. The distance from the
RPE basal lamina to the centre of each organelle was measured
using Image J software [27]. More than 500 mitochondria and 900
melanosomes were quantified from five mice in each group.
Immunostaining
Mouse eyes were fixed in 4% paraformaldehyde, cryopreserved
in OCT embedding matrix and cut into 12 mm sections. Sections
were blocked and permeabilised in PBS containing 5% normal
donkey serum, 1% bovine serum albumin, 0.5% triton X-100 and
0.12% sodium azide. Sections were either stained with a GFAP
antibody conjugated to Cy3 fluorophore (Sigma Aldrich, 1:500
dilution), a DAF antibody (Rat monoclonal antibody, a kind gift
Figure 7. Decay-accelerating factor expression co-localises with glutamine synthetase in Mu¨ller cells. 12 mm PFA-fixed sections from
old Cfh2/2 retinas were stained for DAF (green), glutamine synthetase (red) and nuclei (blue). Maximum intensity projections were made of a 9 mm z-
stack of DAF and nuclei (A and D), glutamine synthetase and nuclei (B and E) or merge (C and F). White boxes of low power images (A-C) indicate
regions where high power images were taken (D-F). GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform
layer; ONL, outer nuclear layer; OLM, outer limiting membrane; PR, photoreceptors. Images are representative of three independent experiments.
Scale bars = 20 mm.
doi:10.1371/journal.pone.0068616.g007
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from Prof. B. Paul Morgan, University of Cardiff, 1:50 dilution) or
double labeled with glutamine synthetase antibody (Millipore,
mouse monoclonal antibody, 1:200 dilution) all overnight at 4uC.
Sections stained with DAF antibody were then washed and stained
with anti-rat IgG conjugated to AlexaFluor 488 (1:200 dilution) for
1 h at RT. Sections dual labeled with glutamine synthetase were
also stained with anti-mouse IgG conjugated to AlexaFluor 555
(1:200 dilution). Sections were again washed and incubated with
1 mg/ml DAPI for 2 min at RT before mounting in Mowial
mounting medium.
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